Company Filing History:
Years Active: 1988-1992
Title: Inventor Spotlight: John W. Goers of Atascadero, CA
Introduction
John W. Goers is an innovative inventor based in Atascadero, California, known for his contributions to the field of porphyrin chemistry. With a total of three patents to his name, Goers' work primarily focuses on the development of therapeutic agents that can significantly impact medical treatments.
Latest Patents
Among his notable inventions, Goers has developed two latest patents. The first, titled "Amine-containing porphyrin derivatives," pertains to porphyrins that are designed to act as photosensitizers. These compounds hold promise as therapeutic agents for various medical applications. The invention also includes methods for creating conjugates where a porphyrin derivative is covalently attached to an antibody or an antibody fragment, enhancing its therapeutic potential through in vivo applications.
The second patent, "Antibody-therapeutic agent conjugates," expands on his earlier work by describing conjugates that combine a therapeutic agent with an antibody or antibody fragment. This invention delineates methods for preparing intermediates that facilitate the production of antibody conjugates, as well as therapeutic methods leveraging these innovative conjugates within living organisms.
Career Highlights
John W. Goers is affiliated with Cytogen Corporation, where he contributes his expertise in the development of novel therapeutic solutions. His extensive experience in the field enhances the company's innovative portfolio and opens new avenues in therapeutic research.
Collaborations
Throughout his career, Goers has collaborated with esteemed colleagues, including Vernon L. Alvarez and John D. Rodwell. These collaborations foster a rich exchange of ideas and techniques, further driving innovative solutions in the therapeutic landscape.
Conclusion
John W. Goers stands out as a noteworthy inventor whose pioneering efforts in porphyrin-based therapeutics continue to influence the medical field. His patents reflect a commitment to advancing healthcare through innovative technologies, showcasing the importance of collaborative efforts in research and development.